Biolinq raises $100M for intradermal glucose sensor for type 2 diabetes
The company's patch uses intradermal electrochemical sensors to monitor glucose levels and provide metabolic insights to individuals with type 2 diabetes not on insulin.

Apr 22, 2025 0
Apr 22, 2025 0
Apr 22, 2025 0
Apr 21, 2025 0
Apr 17, 2025 0
Apr 17, 2025 0
Apr 17, 2025 0
Apr 17, 2025 0
Or register with email
Feb 13, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 19, 2025 0
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.